04 Jun 2020

Pharmaceutical industry proves itself through the coronavirus pandemic

Reading the headlines during the COVID-19 pandemic, you could be forgiven for thinking that the healthcare and pharmaceutical industry was in crisis, with the potential for government intervention, nationalisation and requisitioning. 

In fact, throughout the largest peacetime disruption in modern history, the pharmaceutical industry has proved quietly robust. Resilient supply chains, designed to be crisis proof, kept the industry running while other sectors scrambled to readjust.

 

However, the disruption has brought changes, some of which could be here to stay. Below, we’ve summarised some of the key impacts, using expertise from Investec’s respected healthcare team alongside feedback from our clients...
 

Please complete the form below to read the full article

Investec Bank plc and its subsidiaries recognise and respect the privacy and data protection rights of individuals with regards to personal data.

 

We may use your personal data to provide you with services you request from us, or to manage your accounts, make decisions, detect and prevent fraud, fulfil any contractual relationship with you, undertake analysis and assessment, ensure that we comply with legal and regulatory requirements and/or for other purposes where in our legitimate interests.

 

For further details as to how Investec uses personal data, please refer to our Data Protection Notice.

Sending...

Please complete all required fields before sending.

Thank you for registering your details.

Please contact us if you have any questions.

Sorry there seems to be a technical issue

Discover more from Investec